{
  "actions": [
    {
      "acted_at": "2020-02-26",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2020-02-26",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr5982-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "F000466",
      "district": "1",
      "name": "Fitzpatrick, Brian K.",
      "original_cosponsor": false,
      "sponsored_at": "2020-03-02",
      "state": "PA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001187",
      "district": "11",
      "name": "Meadows, Mark",
      "original_cosponsor": false,
      "sponsored_at": "2020-03-02",
      "state": "NC",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "R000577",
      "district": "13",
      "name": "Ryan, Tim",
      "original_cosponsor": true,
      "sponsored_at": "2020-02-26",
      "state": "OH",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-02-26",
  "number": "5982",
  "official_title": "To direct the Secretary of Health and Human Services to study American dependence on Chinese pharmaceuticals and to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr5927-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Safe Medicine Act",
  "sponsor": {
    "bioguide_id": "P000599",
    "district": "8",
    "name": "Posey, Bill",
    "state": "FL",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-02-26",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Asia",
    "China",
    "Congressional oversight",
    "Drug safety, medical device, and laboratory regulation",
    "Government studies and investigations",
    "Health",
    "Health care costs and insurance",
    "Health information and medical records",
    "Health technology, devices, supplies",
    "Manufacturing",
    "Prescription drugs",
    "Public contracts and procurement",
    "Trade restrictions"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2020-02-26",
    "date": "2021-09-07T20:23:13Z",
    "text": "Safe Medicine Act\n\nThis bill authorizes the Food and Drug Administration to temporarily ban the sale of a drug if (1) the drug (or an active ingredient of the drug) is manufactured in a country that, because of systemic problems of supervision, may be producing contaminated drugs; and (2) the drug's labeling does not have certain warnings about potential contamination.\n\nThe bill also requires the Department of Health and Human Services to report to Congress on vulnerabilities in the U.S. medicine supply chain, including vulnerabilities related to reliance on production from other countries."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Safe Medicine Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To direct the Secretary of Health and Human Services to study American dependence on Chinese pharmaceuticals and to empower the Food and Drug Administration to issue boxed warnings in the case of critical contamination.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Safe Medicine Act",
      "type": "short"
    }
  ],
  "updated_at": "2022-02-09T03:26:38Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr5982.xml"
}